SAN DIEGO, Dec. 9, 2025 – Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced it has filed an amended registration...
Read MoreLAS VEGAS, NEVADA, December 9, 2025 – Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders,...
Read MoreToronto, ON — December 09, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, invites users to explore the philosophy behind its Wellness AI platform. From early concept testing to personal insight features, Aleen Inc....
Read MoreToronto, ON — December 02, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, continues its structured path from early exploration and user testing to personal account development, and now moves into full-scale...
Read MoreKelowna, BC – December 1, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)(“Doseology” or the “Company”) is pleased to announce the launch of its Investor Communications Initiative, designed to...
Read MoreVANCOUVER, BC, November 19, 2025 – BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company”) announces that it has closed its previously announced non-brokered private placement financing (the...
Read MoreLAS VEGAS, NEVADA, November 18, 2025 – Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders,...
Read MoreToronto, ON — November 18, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, announced the completion of its initial concept testing for the upcoming Smart Analytics feature. The research provided valuable insight...
Read MoreVancouver, British Columbia – November 17, 2025 – Scope Technologies Corp. (CSE: SCPE | OTC: SCPCF | FSE: VN8) (“Scope Technologies” or the “Company”) is pleased to announce that it has successfully achieved Level 2...
Read MoreVANCOUVER, BC, November 13, 2025 – BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company”) announces that it has entered into debt settlement agreements with certain creditors of the Company (the...
Read MoreVancouver, British Columbia – November 13, 2025 – Scope Technologies Corp. (CSE: SCPE | OTC: SCPCF | FSE: VN8) (“Scope Technologies”, “QSE” or the “Company”) is pleased to announce...
Read MoreDoseology USA Inc. Kelowna, BC – November 13, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants, is pleased to announce that...
Read More